MAY 24, 2018 12:48 AM PDT

The Link Between Tuberculosis and Parkinson Disease

WRITTEN BY: Nouran Amin

There might be a link between Tuberculosis (TB) and Parkinson’s according to a study published in The EMBO Journal. This link is related to the mechanism behind how our immune system eradicates bacterial infections. More specifically, the study concluded that the mechanism is the same for Tuberculosis and Parkinson.

The findings, which will be published in The EMBO Journal, provide a possible explanation of the cause of Parkinson's disease and suggest that drugs designed to treat Parkinson's might work for TB too.

For Parkinson's disease, the most common genetic mutation occurs on the LRRK2, which allows the LRRK2 protein overactive. By examining the function of LRRK2 in immune cells known as macrophages that are infected with Mycobacterium tuberculosis (Mtb), the bacterium that leads to TB.

Using a combination of experimental approaches, Crick and GSK researchers, in collaboration with Matthias Trost, a proteomics specialist, from Newcastle University, discovered that LRRK2 inhibits phagosomes from fusing with lysosomes, decreasing their efficacy at clearing bacteria. Deletion of the LRRK2 gene or cell treatment using LRRK2 blockers might significantly reduce the levels of Mtb, treating TB. "We think that this mechanism might also be at play in Parkinson's disease, where abnormal masses of protein called 'Lewy bodies' build up in neurons in the brain and cause damage," explains Susanne Herbst, the first author of the study and post-doctoral fellow at the Crick.

Investigators suspect that LRRK2 might inhibit immune cells in the brain from degrading causing a build-up of protein in neurons that disrupts their neuronal function. "By studying TB, we have found a possible explanation for why LRRK2 mutations are a genetic risk factor for Parkinson's disease. It's exciting when different fields of research connect up in unexpected ways like this!" notes Susanne.

The findings also suggest that LRRK2 inhibitors could be a powerful new way for TB treatment. "LRRK2 inhibiting drugs are already being developed to treat Parkinson's disease and we're trying to see if we can repurpose them as a potential new TB therapy. This should be relatively straightforward because TB infects the lungs, so the LRRK2 inhibitors wouldn't need to cross the blood-brain barrier like they do in Parkinson's disease."

Sources: Crick

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 16, 2019
Health & Medicine
OCT 16, 2019
Dietary Cholesterol and Its Impact on Autoimmune and Infectious Disease Processes
There has been a great deal of media coverage and controversy over the role of diet on disease processes such as autoimmunity and infection. Can dietary ch...
OCT 16, 2019
Immunology
OCT 16, 2019
The Morel of the Story
It’s morel mushroom season in the United States and it promises to be a good one! Plenty of rain and warmth favor the growth of this delicatessen, bu...
OCT 16, 2019
Cell & Molecular Biology
OCT 16, 2019
Getting Rid of Damaged Mitochondria Relieves Autoimmune Disease in Mice
Scientists have found a way to inhibit inflammatory molecules that are linked to diseases like lupus and osteoarthritis....
OCT 16, 2019
Plants & Animals
OCT 16, 2019
African Swine Fever a Real Concern as Novel Vaccine Emerges
If you didn’t already know, African swine fever (ASF) is currently ravaging large sums of pigs in the Eastern hemisphere. Wild boars tend to pick up...
OCT 16, 2019
Genetics & Genomics
OCT 16, 2019
Smoking Dads Alter Immune Gene Epigenetics & Increase Risk of Asthma in Kids
Using a group of 1,629 couples, scientists in Taiwan have analyzed the impact of paternal smoking on children....
OCT 16, 2019
Immunology
OCT 16, 2019
This is How Your Immune System Responds to Ebola Vaccination
Vaccines to prevent Ebola are still in their infancy, with experimental-only versions being used only in the most dire of instances. In a new study, scient...
Loading Comments...